News – Page 119 – Endpoints News

FibroGen to shrink US workforce by 75% following more late-stage fails

9 months ago

Vertex gets January decision date for non-opioid pain medicine

9 months ago

Filing a new drug with clinical data in 2025? FDA sets fee at $4.3M

9 months ago

After a year of tumult, Pfizer manages to pull off a boring quarter

9 months ago

FDA shoots down second Novartis petition seeking to halt Entresto generics

9 months ago

China corruption crackdown hits Merck’s Gardasil sales, spooking investors

9 months ago

Behind Boehringer’s up to $1.3B Nerio deal is a budding cancer pipeline and aim to ‘leapfrog AbbVie’

9 months ago

Incyte drops four early-stage programs from its pipeline as part of strategic review

9 months ago

Imunon shares up over 150% as ovarian cancer treatment extends survival in Phase 2

9 months ago

Day One's $175M PIPE; Pinetree raises $17M in Series A

9 months ago

BioNTech, Regeneron claim Phase 2 win for cancer vaccine, PD-1 combo

9 months ago

Pfizer ups 2024 guidance by $1B after multiple rounds of cost cuts

9 months ago

Celldex says antibody drug improves irritable skin condition in Phase 2 test

9 months ago

Exclusive: Startup aims to tackle ‘undruggable’ neuro targets with tech from Kevan Shokat's UCSF lab

9 months ago

Keytruda tops $7B quarterly sales for the first time

9 months ago

Roche begins Phase 2 obesity trial for GLP-1/GIP agonist, striking while iron is hot

9 months ago

Bessemer VC Morgan Cheatham shares how AI healthcare startups can win in a crowded market

9 months ago

AstraZeneca and Daiichi Sankyo fail to win NICE recommendation for Enhertu, call for change to review process

9 months ago

Indivior reaches $86M settlement over its alleged role in the opioid epidemic

9 months ago

Roivant's dealmaker lands $81M cash bonus following drug sale to Roche

9 months ago

Pfizer cuts 210 North Carolina workers after it officially discontinues failed Duchenne gene therapy

9 months ago

FDA's ad enforcer critiques Brittany Mahomes' paid Instagram post for Kaléo

9 months ago

Boehringer Ingelheim buys oncology biotech for up to $1.3B

9 months ago

Ventyx axes development of TYK2 inhibitor following Phase 2 failure

9 months ago

First page Previous page 116 117 118119120 121 122 Next page Last page